A macroscopic singlet oxygen model for photodynamic therapy (PDT) has been used extensively to calculate the reacted singlet oxygen concentration for various photosensitizers. The four photophysical parameters (ξ, σ, β, δ) and threshold singlet oxygen dose ([   1   O2 ]r,sh) can be found for various drugs and drug-light intervals using a fitting algorithm. The input parameters for this model include the fluence, photosensitizer concentration, optical properties, and necrosis radius. An additional input variable of photobleaching was implemented in this study to optimize the results. Photobleaching was measured by using the pre-PDT and post-PDT sensitizer concentrations. Using the RIF model of murine fibrosarcoma, mice were treated with a linear source with fluence rates from 12 -150 mW/cm and total fluences from 24 -135 J/cm. The two main drugs investigated were benzoporphyrin derivative monoacid ring A (BPD) and 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH). Previously published photophysical parameters were fine-tuned and verified using photobleaching as the additional fitting parameter. Furthermore, photobleaching can be used as an indicator of the robustness of the model for the particular mouse experiment by comparing the experimental and model-calculated photobleaching ratio.
INTRODUCTION
Photodynamic therapy (PDT) is a cancer treatment modality for cancer and other localized diseases. PDT incorporates light, photosensitizer (PS), and oxygen ( 3 O2) to create activated singlet oxygen ( 1 O2) to kill cells. PDT is uniquely advantageous compared to other treatment modalities as it can be locally delivered, it is non-ionizing, it has fast post-operative recovery, and it has a good cosmetic outcome [1] . An explicit macroscopic singlet oxygen dosimetry model to determine the PDT outcome has been previously developed and studied for various sensitizers [2 -6] . This explicit dosimetry model can be used to improve treatment planning and predictions of treatment outcomes in clinical settings, since light dose or PDT dose alone is not sufficient as a dosimetric quantity. Particularly in hypoxic environments, PDT dose, i.e., the light energy absorbed by the photosensitizer, is a poor predictor of PDT outcome. Both theoretical and experimental mouse studies have shown that in tumors, which are poorly oxygenated to start with, high fluence rate PDT can create even more hypoxic environments [2] . Furthermore, since direct measurement of the production of 1 O2 is difficult due to its short lifetime of around 30 -180 ns, an explicit model can be used to assess PDT outcome in vivo.
Photobleaching is the destruction of the photosensitizer through photochemical reactions in the PDT process. The highly reactive singlet oxygen can interact with molecular targets, inducing cell death and necrosis as desired, or it can react with the ground state sensitizer to cause photobleaching. The mechanism investigated utilized in this study is highlighted in Figure 1 .
In the previous studies, measured necrosis radius was compared to the calculated necrosis radius and used as the optimization function. Catheter insertion or improper sectioning of the tumor can create discrepancies in the necrosis radius readings. Therefore, an additional optimization variable can be incorporated into the model to improve the fitting algorithm and find the desired photosensitizer parameters. Furthermore, this can be used as a measure of the quality of the data overall. The four major photochemical parameters (ξ, σ, β, δ) and threshold singlet oxygen dose ([ 1 O2]r,sh) for the singlet oxygen model have been investigated and determined for the photosensitizer BPD and HPPH using photobleaching as this additional optimization variable. 
MATERIALS AND METHODS

Tumor Model
Radioactively induced fibrosarcoma (RIF) cells were cultured and injected subcutaneously at 1×10 7 cells/ml in the right shoulders of 6 -8 week old female C3H mice (NCI-Frederick, Frederic, MD). Animals were under the care of the University of Pennsylvania Laboratory Animal Resources. All studies were approved by the University of Pennsylvania Institutional Animal Care and Use Committee. The fur of the tumor region was clipped prior to cell inoculation, and the treatment area was depilated with Nair at least 24 hours before measurements.
Macroscopic Singlet Oxygen Model
A macroscopic singlet oxygen model was used in this study. It has been previously described [2 -6] . The theory is derived from reaction rate equations for a type II PDT mechanism. The photochemical reactions can be simplified to four coupled differential equations as follows
Here, ϕ is the light fluence rate and S is the source power term. The other parameters used for this study as well as the reaction rate constants (k0,1,2,…,7) are described in Table 1 . 
Macroscopic oxygen maximum perfusion rate
For a given value of light fluence rate, ϕ, spatially resolved light fluence rate profiles can be constructed using equation (1) , which will then be used in the calculation of the PDT kinetics equations (Eqs. (2)- (4)). Equation (2) can be used to determine the predicted amount of photobleaching by calculating the ratio of sensitizer concentration after the treatment time has passed (post-PDT PS concentration) and the initial sensitizer concentration. This was the value of the predicted photobleaching amount.
Parameter Determination Studies
Determination of the photophysical parameters were done by previous studies involving partial treatment and determination of the necrosis radius of tumors [2 -6] . Photosensitizer was via tail vein at a concentration of 1 mg/kg for BPD. Treatment was delivered using a 690 nm laser either 3 hours or 15 minutes after the injection. For the HPPH studies, sensitizer was administered at a concentration of 0.25 mg/kg, and treatment light of 665 nm was delivered 24 hours after injection.
Two catheters were inserted parallel into tumors. A 1 cm long cylindrically diffusing fiber was inserted into one catheter to deliver treatment light. The other catheter was used to insert a detector to measure light fluence inside the tumor as well as obtain a profile to determine the tumor optical properties. A side-firing fiber was also inserted to measure fluorescence excited by 405 nm light both before and after treatment to determine the amount of photobleaching. Several experiments were performed using 13 different treatment conditions. Necrosis radius was determined for each tumor by measuring the areas of necrosis on digitally scanned slides of tumor sections stained with hematoxylin and eosin (H & E).
Using the light, sensitizer, and necrosis radius as input parameters, fitting was performed in Matlab (Natick, MA) to determine the photophysical parameters of each drug and drug-light interval (DLI). An initial guess of ξ, σ, β, δ, and [ 1 O2]rx,sh were put into the governing differential equations described in section 2. 
Here, [ 1 O2]rx,i(rn) is the computed reacted singlet oxygen at necrosis radius rn for the i-th mouse (or group of mice).
Incorporation of Photobleaching
In this study, a second objective function of the following form was implemented
Parameters were fitted both with and without this second objective function and compared to see which method provided global minima with smaller errors. As mentioned in section 2.3, measured photobleaching was obtained by comparing the pre-and post-PDT sensitizer concentrations via fluorescence spectra analysis. Calculated, or predicted, photobleaching was determined by calculating sensitizer concentration before and after treatment using equation (2) . Percent photobleaching was defined as the fraction of initial sensitizer that was photobleached. If all of the sensitizer had bleached by the end of treatment, this value would be 100%.
RESULTS
Incorporation of the photobleaching objective function showed an improvement in the optimization of the photosensitizer photochemical parameters. Figure 1 shows that by considering the theoretical photobleaching percent as calculated by using equation (2) and comparing them to the measured values, it is possible to improve the fitted results. These improved values are summarized for BPD in Tables 2 and 3 . Necosis radius alone may be susceptible to large error due to the nature of how measurements are done. Incorporation of the photobleaching characteristics may help to reduce the effect of this uncertainty in fitting for the photophysical parameters. Table  1 and 2 In addition to these results, the effect of fluence rate on photobleaching ratio was observed, as shown in Figure 2 . With a higher fluence rate, or treatment delivery source strength, there is a lower rate of photobleaching. For efficient PDT, there needs to be sufficient amounts of oxygen maintained in the environment. With higher fluence rates, there is faster oxygen consumption (more oxygen depletion), resulting in less efficient PDT. Conversely, with lower fluence rates, the environmental oxygen concentration in the tumor is not depleted as quickly; therefore, the PDT is more efficient and there is more photobleaching. Irreversible photobleaching reduces the sensitizer concentration and hence the rate of photochemical oxygen consumption. These effects have been seen previously in other studies for both cells and in vivo models with different drugs [7 -11] . 
CONCLUSION
Photobleaching was incorporated as an optimization parameter for an explicit singlet oxygen model. Furthermore, photobleaching can be used as an indicator of the robustness of the model for the particular mouse experiment by comparing the experimental and model-calculated photobleaching percent with the experimentally measured amount of photobleaching. Measured necrosis radius can have large errors due to the experimental technique; therefore, addition of photobleaching can help to further minimize uncertainty in the fitting algorithm. The photophysical parameters fitted are improved with smaller error margins overall. Furthermore, the fluence rate effect on photobleaching was observed. This study can further be improved by implementing the second optimization function computationally (versus manual selection) as well as measuring the sensitizer concentration continuously during treatment to better model the photobleaching. Continuous monitoring of the sensitizer can provide more information about the fluence rate effect as well as more accurately characterize the photobleaching timecourse.
